Browse through our press and news section by category:

05.02.2013, SCHOTT AG, Mainz (Germany) / Paris (France)

SCHOTT Pharmaceutical Systems to participate in Pharmapack Europe 2013

Mainz/Paris, February 5, 2013 – SCHOTT Pharmaceutical Systems, one of the world’s leading suppliers of high-quality primary pharmaceutical packaging, will be exhibiting at Pharmapack Europe in Paris. From February 13-14, 2013, the main focus of SCHOTT’s booth 383 will be on the innovative pharmaceutical packaging solutions the international technology group offers. In addition to delamination-resistant vials, the portfolio includes pre-fillable syringes, ampoules and cartridges. Furthermore, the employees of “SCHOTT Pharma Services” will be presenting their range of analytical laboratory services for primary pharmaceutical packaging products.

“SCHOTT considers Pharmapack Europe, the most important European trade exhibition on pharmaceutical packaging, to be an important meeting point and an excellent platform for presenting its solutions, competences and products,” says Jean-Yves Grandemange, Director, Sales EMEA at SCHOTT Pharmaceutical Packaging. “We are particularly pleased to see this year's event focus more closely on the patient. With the solutions and products we offer, we help the pharmaceutical industry to guarantee the safety and stability of medications. In the end, this also lowers the risks for patients,” he adds.

The product highlights SCHOTT will be showing at Pharmapack Europe

With its Type I plus®, SCHOTT will be presenting its line of delamination-resistant vials. SCHOTT Type I plus® vials are particularly well-suited for storing pharmaceutical products that require a higher level of protection than conventional Type I glass offers, for instance biopharmaceutical proteins that have a tendency to experience denaturation, but also formulations that interact strongly with containers. SCHOTT Type I plus® features a coating on the inside that covalently bonds with the glass matrix and drastically reduces interactions between the glass surface and the medication. This, in turn, protects the medications and helps them to remain stable. Thanks to their outstanding barrier properties, these vials are ideally suited for all types of conventional pharmaceutical processing steps like washing, autoclaving, sterilization and depyrogenation.

Pre-fillable syringes from SCHOTT are used together with parenteral medications in the pharmaceutical, cosmetics and biotech industries. To meet more specific demands, SCHOTT offers a wide range of syringe solutions that are made of glass and polymers. SCHOTT glass syringes, for instance, are manufactured out of high-quality SCHOTT Fiolax® Type I glass tubing on fully automated production lines. These products are available in sizes of between 0.5 and 3 ml with staked needles, luer cones or luer lock adapters. The syringes are washed, siliconized and given either a tip cap or a needle shield. Packaged in nests and tubs, they can be used in aseptic filling immediately.

The pre-fillable polymer syringes from SCHOTT, on the other hand, are manufactured out of COC (cyclic olefin copolymer). SCHOTT polymer syringes are resistant to breakage, light and transparent, yet offer superior barrier properties than conventional polymer syringes. This product can also be used in aseptic filling immediately. No ions or heavy metals are released and it contains a lower level of particles than syringes made of glass. SCHOTT polymer syringes are available in sizes of between 1 and 50 ml with an integrated luer lock. This ensures higher durability and means easier administration for the patient.

About Pharmapack Europe
Pharmapack Europe is being held this year for the twelfth time. 280 exhibitors from more than 27 countries and over 3,000 visitors are expected to attend this trade exhibition on packaging and drug administration systems for the pharmaceutical industry. For the first time ever, the focus of this year's event will be on the patient, who happens to be extremely important when it comes to developing new drug administration systems and pharmaceutical packaging. A two-day conference and several technical workshops will round off the exhibition program.

About SCHOTT
SCHOTT is an international technology group with more than 125 years of experience in the areas of specialty glasses and materials and advanced technologies. SCHOTT ranks number one in the world with many of its products. Its core markets are the household appliance, pharmaceuticals, electronics, optics, solar power, transportation and architecture industries. The company is strongly committed to contributing to its customers’ success and making SCHOTT an important part of people’s lives with high-quality products and intelligent solutions. SCHOTT is committed to managing its business in a sustainable manner and supporting its employees, society and the environment. The SCHOTT Group maintains close proximity to its customers with manufacturing and sales units in all major markets. Its workforce of around 17,000 employees generated worldwide sales of approximately 2.9 billion euros for the 2010/2011 fiscal year. SCHOTT AG, with its headquarters in Mainz (Germany) is owned by the Carl Zeiss Foundation.
Press contact
SCHOTT AG
Christina Rettig
PR Manager
Hattenbergstraße 10
55122 Mainz
Phone: +49 (0)6131/66-4094
Fax: +49 (0)3641/2888-9141
Further information
SCHOTT AG
Klaus Bernhard Hofmann
Vice President Corporate Public Relatio
Hattenbergstraße 10
55122 Mainz
Germany
Phone: +49 6131/66-3662
Fax: +49 3641/2888-9140
SCHOTT uses Cookies on this Website to enhance the user experience and provide the best possible Service. By continuing to browse the Website, you consent to our use of Cookies.